The present invention relates to compounds of formula (I) that are inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions: Formula (I)
                            本发明涉及式(I)的化合物,它们是肿瘤坏死因子受体I的
抑制剂,包括这种化合物的组合物,以及使用这种化合物和组合物在TNF-α介导的疾病治疗中的方法:式(I)